162 related articles for article (PubMed ID: 35297277)
1. Prognostic value of pre-treatment advanced lung cancer inflammation index in non-small cell lung cancer: a meta-analysis.
Tang Y; Ji Y; Yang M
Biomarkers; 2022 Jul; 27(5):441-447. PubMed ID: 35297277
[TBL] [Abstract][Full Text] [Related]
2. The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis.
Liu XR; Wang LL; Zhang B; Liu XY; Li ZW; Kang B; Yuan C; Wei ZQ; Peng D
World J Surg Oncol; 2023 Mar; 21(1):81. PubMed ID: 36879283
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis.
Hua X; Chen J; Wu Y; Sha J; Han S; Zhu X
World J Surg Oncol; 2019 Nov; 17(1):177. PubMed ID: 31677642
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Advanced Lung Cancer Inflammation Index in Patients with Lung Cancer: A Meta-Analysis.
Zhang Y; Chen B
Dis Markers; 2019; 2019():2513026. PubMed ID: 31354887
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1149-1156. PubMed ID: 33906307
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection.
Wang Y; Lin L; Ji Y; Mei X; Zhao C; Chen Y; Che G
Ann Palliat Med; 2020 May; 9(3):721-729. PubMed ID: 32312059
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis.
Wang Z; Wang Y; Zhang X; Zhang T
Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
Li X; Zhang S; Lu J; Li C; Li N
Front Surg; 2022; 9():922595. PubMed ID: 36090319
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
Li J; Wang Y; Li J; Che G
Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
[TBL] [Abstract][Full Text] [Related]
10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy.
Zhang L; Zhao K; Kuang T; Wang K; Chai D; Qiu Z; Liu R; Deng W; Wang W
BMC Cancer; 2023 Jan; 23(1):101. PubMed ID: 36717809
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis.
Wu Y; Song W; Wang D; Chang J; Wang Y; Tian J; Zhou S; Dong Y; Zhou J; Li J; Zhao Z; Che G
World J Surg Oncol; 2023 Jun; 21(1):190. PubMed ID: 37349739
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Fan G; Zhang K; Ding J; Li J
Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
[TBL] [Abstract][Full Text] [Related]
15. Advanced Lung Cancer Inflammation index: a prognostic score in patients with metastatic non-small cell lung cancer.
Bacha S; Sghaier A; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Chabbou A; Megdiche ML
Tunis Med; 2017 Novembre; 95(11):976-981. PubMed ID: 29877556
[TBL] [Abstract][Full Text] [Related]
16. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
Tomita M; Ayabe T; Nakamura K
Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
18. Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
Ozyurek BA; Ozdemirel TS; Ozden SB; Erdoğan Y; Ozmen O; Kaplan B; Kaplan T
Clin Respir J; 2018 Jun; 12(6):2013-2019. PubMed ID: 29356383
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Pretreatment Geriatric Nutrition Risk Index in Lung Cancer Patients: A Meta-Analysis.
Wang Y; Luo L; Li J; Wang Y; Che G; Xie X
Nutr Cancer; 2022; 74(9):3164-3171. PubMed ID: 35373678
[TBL] [Abstract][Full Text] [Related]
20. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]